Infinity Pharmaceuticals Inc INFI:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/04/21 EST
2.67quote price arrow down-0.09 (-3.26%)
Volume
59,782
Close
2.76quote price arrow down-0.14 (-4.83%)
Volume
4,474,708
52 week range
0.60 - 5.98

...

Loading . . .

KEY STATS

  • Open2.98
  • Day High3.06
  • Day Low2.47
  • Prev Close2.76
  • 52 Week High5.98
  • 52 Week High Date02/11/21
  • 52 Week Low0.60
  • 52 Week Low Date03/17/20
  • Market Cap232.23M
  • Shares Out84.14M
  • 10 Day Average Volume3.27M
  • Dividend-
  • Dividend Yield-
  • Beta2.32
  • 1 Year % Change142.11

RATIOS/PROFITABILITY

  • EPS (TTM)-0.71
  • P/E (TTM)-3.88
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-39.317M
  • ROE (MRQ)-1,839.35%
  • Revenue (MRQ)1.59M
  • Gross Margin (MRQ)39.76%
  • Net Margin (MRQ)-2,592.65%
  • Debt To Equity (MRQ)-0.00%

EVENTS

  • Earnings Date05/10/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Infinity Pharmaceuticals Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Infinity Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and delivery of medicines to treat diseases. The Company develops small molecule drugs that target disease pathways for potential applications in oncology. Its product candidate is duvelisib, also known as IPI-145, is an oral, dual-inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K), for the treatment of hematologic malignancies, or...
Adelene Perkins
Chairman
Lawrence Bloch M.D. J.D.
President
Address
1100 Massachusetts Ave Ste 4
Cambridge, MA
02138-5241
United States